{"pmid":32474929,"title":"Rapid publishing in the era of coronavirus disease 2019 (COVID-19).","text":["Rapid publishing in the era of coronavirus disease 2019 (COVID-19).","Med J Aust","Lee, Adrian Ys","Lin, Ming-Wei","32474929"],"journal":"Med J Aust","authors":["Lee, Adrian Ys","Lin, Ming-Wei"],"date":"2020-06-01T11:00:00Z","year":2020,"_id":"32474929","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.5694/mja2.50617","keywords":["covid-19","infectious diseases","publishing","respiratory tract infections"],"weight":0,"_version_":1668341932697321472,"score":9.490897,"similar":[{"pmid":32474933,"title":"Rapid publishing in the era of coronavirus disease 2019 (COVID-19).","text":["Rapid publishing in the era of coronavirus disease 2019 (COVID-19).","Med J Aust","Talley, Nicholas J","32474933"],"journal":"Med J Aust","authors":["Talley, Nicholas J"],"date":"2020-06-01T11:00:00Z","year":2020,"_id":"32474933","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.5694/mja2.50625","keywords":["covid-19","infectious diseases","publishing","respiratory tract infections"],"weight":0,"_version_":1668341932697321473,"score":148.43813},{"pmid":32400020,"title":"Coronavirus disease 2019 (COVID-19) and implications for thiopurine use.","text":["Coronavirus disease 2019 (COVID-19) and implications for thiopurine use.","Med J Aust","Goodsall, Thomas M","Costello, Samuel P","Bryant, Robert V","32400020"],"journal":"Med J Aust","authors":["Goodsall, Thomas M","Costello, Samuel P","Bryant, Robert V"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32400020","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.5694/mja2.50613","keywords":["covid-19","immunosuppression","infectious diseases","inflammatory bowel diseases","respiratory tract infections","virus diseases"],"topics":["Treatment"],"weight":1,"_version_":1666865855012536320,"score":65.70994},{"pmid":32372435,"title":"Drug repurposing in the era of COVID-19: a call for leadership and government investment.","text":["Drug repurposing in the era of COVID-19: a call for leadership and government investment.","Med J Aust","Martin, Jennifer H","Bowden, Nikola A","32372435"],"journal":"Med J Aust","authors":["Martin, Jennifer H","Bowden, Nikola A"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32372435","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.5694/mja2.50603","keywords":["covid-19","drug industry","drugs, generic","infectious diseases","medicine, traditional","policy, drugs and alcohol","respiratory tract infections","virology"],"topics":["Treatment"],"weight":1,"_version_":1666138496371261443,"score":64.81713},{"pmid":32504015,"title":"Will the pandemic permanently alter scientific publishing?","text":["Will the pandemic permanently alter scientific publishing?","Nature","Callaway, Ewen","32504015"],"journal":"Nature","authors":["Callaway, Ewen"],"date":"2020-06-07T11:00:00Z","year":2020,"_id":"32504015","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1038/d41586-020-01520-4","keywords":["peer review","publishing","sars-cov-2"],"topics":["General Info"],"weight":1,"_version_":1668892488375468032,"score":64.23768},{"pmid":32441063,"title":"Coronavirus disease 2019 (COVID-19): angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and cardiovascular disease.","text":["Coronavirus disease 2019 (COVID-19): angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and cardiovascular disease.","Med J Aust","Jennings, Garry Lr","32441063"],"journal":"Med J Aust","authors":["Jennings, Garry Lr"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32441063","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.5694/mja2.50622","keywords":["covid-1","hypertension","infectious diseases","respiratory tract infections"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1667523504774316032,"score":63.890747}]}